Ledyard National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Ledyard National Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	468 +11	+2%	+$4.88K	0.02%	236
2026 Q1	$204K	Buy	457 +4	+0.9%	+$1.86K	0.02%	233
2025 Q4	$205K	Buy	+453	New	+$195K	0.02%	239
2023 Q3	–	Sell	-710	Closed	-$250K	–	205
2023 Q2	$250K	Buy	+710	New	+$239K	0.03%	191

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Ledyard National Bank's VRTX Position: Q2 2026 in Review

Ledyard National Bank increased its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, buying an estimated $4.88K and bringing the position to 468 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #236.

Ledyard National Bank first reported a position in VRTX in Q2 2023 and has held it in 4 quarters since. The position peaked at $250K in Q2 2023. 734 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Ledyard National Bank held 468 shares of Vertex Pharmaceuticals worth $232K as of Q2 2026.
Ledyard National Bank bought 11 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.88K.
Vertex Pharmaceuticals made up 0.02% of Ledyard National Bank's portfolio in Q2 2026, its #236 holding.
Ledyard National Bank first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
Ledyard National Bank's Vertex Pharmaceuticals position peaked at $250K in Q2 2023.
734 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.